SMTL ID : 6ztr.2 (1 other biounit)

Crystal Structure of the anti-human P-Cadherin Fab CQY684 in complex with human P-Cadherin(108-324)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

hetero-1-1-1-mer

Ligands

3 x CA: CALCIUM ION(Non-covalent)

CA.1: 6 residues within 4Å: Chain B: N.104, H.106, D.136, D.138, N.145, D.197 5 PLIP interactions: 5 interactions with chain B Metal complexes: B:H.106, B:D.136, B:D.136, B:D.138, B:N.145 CA.2: 6 residues within 4Å: Chain B: E.13, E.71, D.102, Q.103, D.105, D.138 5 PLIP interactions: 5 interactions with chain B Metal complexes: B:E.13, B:D.102, B:Q.103, B:D.105, B:D.138 CA.3: 4 residues within 4Å: Chain B: E.13, D.69, E.71, D.105 6 PLIP interactions: 4 interactions with chain B, 2 Ligand-Water interactions Metal complexes: B:E.13, B:D.69, B:E.71, B:D.105, H2O.6, H2O.7

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sheng, Q. et al., PCA062, a P-cadherin Targeting Antibody-Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin-expressing Malignancies. Mol.Cancer Ther. (2021)

Release Date

2021-05-05

Peptides

CQY684 Fab heavy-chain: A
Cadherin-3: B
CQY684 Fab light-chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
I

C
L

CQY684 Fab heavy-chain

Cadherin-3

CQY684 Fab light-chain

Related Entries With Identical Sequence